2026-08-01 (六) 15:00 ~ 18:10

2026-08-02 (日) 09:00 ~ 12:00

New Horizons: Pursuing Excellence in Lung Cancer Treatment brings together leading thoracic oncology experts from across Taiwan to explore the latest advances and evolving treatment paradigms in lung cancer management. Over two days of scientific exchange, participants will review key updates from ASCO 2026, discuss emerging evidence in adjuvant ALK-targeted therapy, EGFR TKI treatment strategies, HER2-positive lung cancer, and combination treatment strategies involving immunotherapy and anti-VEGF agents.

The program will also highlight the growing role of real-world evidence in clinical decision-making, examine optimal treatment sequencing for EGFR and ALK-positive NSCLC, and address innovations in molecular diagnostics, including alternative liquid biopsy approaches. Through expert-led presentations and interactive discussions, the meeting aims to provide practical insights into maximizing patient outcomes across diverse clinical settings while navigating the rapidly evolving landscape of precision oncology.